1-(1-BENZYLPYRROLIDIN-3-YL)CYCLOBUTAN-1-OL, 95.0%, 250mg

2,5-norbornadieno, 97 %, 50 ml, envase de vidrio

5-Bromo-4-fluoro-1H-indole, 95.0%, 25g

2,2-Dimethoxy-7-azaspiro[3.5]nonane, 98%, 1g

1-(Pyridin-4-ylmethyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxylic acid, 1g

3-Hydrazino-5-(4-methoxyphenyl)-1,2,4-triazine, 95.0%, 5g

Methyl 3-(4-hydroxyphenyl)hex-4-ynoate, 95%, 100mg

2-Bromoethyl phenyl sulfide, 97.0%, 5g

Methyl L-azetidine-2-carboxylate hydrochloride, 97.0%, 5g

(2R,3S,4R,5S,6S)-2-((5-bromo-4-chloro-1H-indol-3-yl)oxy)-6-methyltetrahydro-2H-pyran-3,4,5-triol, 98%, 500mg

1-Bromo-2-iodo-4-(trifluoromethoxy)benzene, 97%, 5g

N-(4-Chloro-3-fluorophenyl)-7-methoxy-6-nitroquinazolin-4-amine (Dacomitinib Impurity), 98%, 50mg

3-Oxo-3-piperidin-1-ylpropanenitrile, 97.0%, 1g